Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 23;12(23):7261.
doi: 10.3390/jcm12237261.

Prognostic Impact of the UMIPIC Program in the Follow Up in Patients with Heart Failure and Cardiorenal Syndrome

Manuel Méndez-Bailón  1 , Noel Lorenzo-Villalba  2 , Álvaro González-Franco  3 , Luis Manzano  4 , Jesús Casado-Cerrada  5 , José M Cerqueiro  6 , José Pérez-Silvestre  7 , José Carlos Arévalo-Lorido  8 , Alicia Conde-Martel  9 , Melitón Francisco Dávila-Ramos  10 , Margarita Carrera-Izquierdo  11 , Emmanuel Andrès  2 , Manuel Montero-Pérez-Barquero  12
Affiliations

Prognostic Impact of the UMIPIC Program in the Follow Up in Patients with Heart Failure and Cardiorenal Syndrome

Manuel Méndez-Bailón et al. J Clin Med. .

Abstract

Background: Individuals suffering from heart failure (HF) and cardiorenal syndrome (CRS) represent a special group of patients considering their age, multiple health issues, and treatment challenges. These factors make them more susceptible to frequent hospital stays and a higher mortality rate. UMIPIC is a multidisciplinary care model program for patients with heart failure follow up provided by internists and nurses who are experts in this entity. Our study delved into the effectiveness of this specialized care program (UMIPIC) in mitigating these risks for HF and CRS patients.

Methods: We analyzed the medical records of 3255 patients diagnosed with HF and CRS types 2 and 4, sourced from the RICA registry. These patients were divided into two distinct groups: those enrolled in the UMIPIC program (1205 patients) and those under standard care (2050 patients). Using propensity score matching, we ensured that both groups were comparable. The study focused on tracking hospital admissions and mortality rates for one year after an HF-related hospital stay.

Results: Patients in the UMIPIC group experienced fewer hospital readmissions due to HF compared to their counterparts (20% vs. 32%; Hazard Ratio [HR] = 0.48; 95% Confidence Interval [95% CI]: 0.40-0.57; p < 0.001). They also showed a lower mortality rate (24% vs. 36%; HR = 0.64; 95% CI: 0.54-0.75; p < 0.001). Furthermore, the UMIPIC group had fewer total hospital admissions (36% vs. 47%; HR = 0.58; 95% CI: 0.51-0.66; p < 0.001).

Conclusions: The UMIPIC program, centered on holistic and ongoing care, effectively reduces both hospital admissions and mortality rates for HF and CRS patients after a one-year follow-up period.

Keywords: UMIPIC; cardiorenal syndrome; heart failure.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Patient flow chart. Legend: RICA registry (Registro Nacional de Pacientes con Insuficiencia Cardiaca) (RICA); CRS: Cardiorenal syndrome; Unidad de Manejo Integral del Paciente con Insuficiencia Cardiaca (UMIPIC).
Figure 2
Figure 2
Kaplan–Meier curves for HF admission during the follow-up year.
Figure 3
Figure 3
Kaplan–Meier curves for mortality during the follow-up year.
See this image and copyright information in PMC

References

    1. Rodríguez-Artalejo F., Banegas Banegas J.R., Guallar-Castillón P. Epidemiología de la insuficiencia cardíaca [Epidemiology of heart failure] Rev. Esp. Cardiol. 2004;57:163–170. doi: 10.1016/S0300-8932(04)77080-3. - DOI - PubMed
    1. Sayago-Silva I., García-López F., Segovia-Cubero J. Epidemiology of heart failure in Spain over the last 20 years. Rev. Esp. Cardiol. 2013;66:649–656. doi: 10.1016/j.recesp.2013.03.014. - DOI - PubMed
    1. Sicras-Mainar A., Sicras-Navarro A., Palacios B., Varela L., Delgado J.F. Epidemiology and treatment of heart failure in Spain: The HF-PATHWAYS study. Rev. Esp. Cardiol. 2022;75:31–38. doi: 10.1016/j.recesp.2020.09.014. - DOI - PubMed
    1. Conde Martel A. Heart and kidneys, poor travel companions from the start of heart failure. Rev. Clin. Esp. 2020;220:569–570. doi: 10.1016/j.rce.2019.12.006. - DOI - PubMed
    1. Virzì G., Day S., de Cal M., Vescovo G., Ronco C. Heart-kidney crosstalk and role of humoral signaling in critical illness. Crit. Care. 2014;18:201. doi: 10.1186/cc13177. - DOI - PMC - PubMed